Last €112.82 EUR
Change Today +0.278 / 0.25%
Volume 75.0
As of 1:56 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for bayer ag-sponsored adr (BAYA)

Although debt as a percent of total capital decreased at Bayer AG over the last fiscal year to 25.68%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 68.29 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 133.30 days.
View Balance Sheet In U.S. Dollar
Currency in
Millions of Euros
As of:Dec 31
2010
Reclassified
EUR
Dec 31
2011
Reclassified
EUR
Dec 31
2012
Restated
EUR
Dec 31
2013
EUR
4 Year
Trend
Assets    
Cash and Equivalents2,840.01,770.01,698.01,662.0
Short-Term Investments585.0590.0143.0138.0
Trading Asset Securities----196.0--
TOTAL CASH AND SHORT TERM INVESTMENTS3,425.02,360.02,037.01,800.0
Accounts Receivable6,669.07,061.07,458.07,569.0
Notes Receivable129.01,931.088.067.0
Other Receivables1,496.01,785.01,826.01,649.0
TOTAL RECEIVABLES8,294.010,777.09,372.09,285.0
Inventory6,104.06,368.06,991.07,129.0
Other Current Assets495.0563.0610.0814.0
TOTAL CURRENT ASSETS18,318.020,068.019,010.019,028.0
Gross Property Plant and Equipment26,262.027,076.028,025.028,455.0
Accumulated Depreciation-16,427.0-17,253.0-18,127.0-18,440.0
NET PROPERTY PLANT AND EQUIPMENT9,835.09,823.09,898.010,015.0
Goodwill9,002.09,160.09,293.09,862.0
Long-Term Investments628.0595.0528.0459.0
Accounts Receivable, Long Term32.035.09.08.0
Loans Receivable, Long Term654.0804.0754.0748.0
Deferred Tax Assets, Long Term1,174.01,311.01,579.01,596.0
Deferred Charges, Long Term969.0809.0920.0673.0
Other Intangibles10,223.09,516.08,571.08,270.0
Other Long-Term Assets671.0644.0756.0658.0
TOTAL ASSETS51,506.052,765.051,318.051,317.0
    
LIABILITIES & EQUITY    
Accounts Payable3,497.03,779.04,305.04,473.0
Accrued Expenses782.0815.0782.02,983.0
Current Portion of Long-Term Debt/Capital Lease1,527.03,235.02,205.02,160.0
Current Portion of Capital Lease Obligations50.053.0235.051.0
Current Income Taxes Payable62.076.072.0101.0
Other Current Liabilities, Total4,864.05,349.05,610.04,184.0
Unearned Revenue, Current103.0136.0130.0122.0
TOTAL CURRENT LIABILITIES10,835.013,390.013,104.014,023.0
Long-Term Debt9,169.07,185.06,399.04,713.0
Capital Leases512.0501.0307.0331.0
Minority Interest130.0120.0100.0135.0
Unearned Revenue, Non-Current238.0253.0216.0197.0
Pension & Other Post-Retirement Benefits7,305.07,870.09,246.07,368.0
Deferred Tax Liability Non-Current2,577.02,116.0935.01,193.0
Other Non-Current Liabilities1,907.02,118.02,560.02,639.0
TOTAL LIABILITIES32,543.033,433.032,767.030,464.0
Common Stock2,117.02,117.02,117.02,117.0
Additional Paid in Capital6,167.06,167.06,167.06,167.0
Retained Earnings12,345.012,755.011,861.014,817.0
Comprehensive Income and Other-1,796.0-1,827.0-1,694.0-2,383.0
TOTAL COMMON EQUITY18,833.019,212.018,451.020,718.0
TOTAL EQUITY18,963.019,332.018,551.020,853.0
TOTAL LIABILITIES AND EQUITY51,506.052,765.051,318.051,317.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYA:GR €112.82 EUR +0.278

BAYA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,449 GBp -41.50
Merck & Co Inc $57.63 USD +0.83
Pfizer Inc $31.12 USD +0.45
Sanofi €74.10 EUR +0.62
Dow Chemical Co/The $44.55 USD +1.84
View Industry Companies
 

Industry Analysis

BAYA

Industry Average

Valuation BAYA Industry Range
Price/Earnings 24.3x
Price/Sales 2.2x
Price/Book 4.4x
Price/Cash Flow 24.3x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-SPONSORED ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.